Search

Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management

Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.

Innovation, animal well-being and productivity

Boehringer Ingelheim reinforces its focus on innovation, animal well-being and productivity. Click here to learn and find out more information.

Our Employees

We offer our employees demanding and challenging tasks. Boehringer Ingelheim needs employees who innovate. Learn more about our employees here.

Our Partnering Culture

We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives. Find out more about our partnering culture.

Our Health and Safety initiative - BE SAFE

We strive to keep our employees in good health, supporting their well-being across all working environments. Learn about our BE SAFE initiative.

COVID-19 Protecting Our Employees

We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.

The power of our people

Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity; a key element of our culture. Click here to find out more information.

Our Commitment

We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.

Our Approach

As a family-owned company, we are driven by the ambition to serve humankind by improving human and animal health. Find out more about our approach here.

Animal Health: Our Responsibility

The importance of sustainability and of the interconnection between human, animal and environmental health is firmly anchored in our philosophy.

Our Responsibility

Our responsibility here at Boehringer Ingelheim to our patients is by serving people through research into diseases with unmet needs. Learn more here.

The Core of our Leitbild

Click here to find out about the core of our leitbild. Here you can find out information about who we are and what we strive for at Boehringer Ingelheim.

More Green

Our MORE GREEN pillar encompasses environmental initiatives that consider many different aspects. Click here to learn more about our MORE GREEN pillar.

Our Contribution

Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come. Click here to find out more.

Our Stories

Boehringer Ingelheim has many initiatives we would like to share. Find out more about us here by reading our press releases, news stories, and more.

Sustainable Development - Our Commitment

View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better.

Our Global Support Program

Our Global Support Program aims to bring more financial relief, protective materials and more to healthcare institutions and communities in need.

Our FOCUS

Here we look at the importance of knowing your source when purchasing medicines to protect yourself. Click here to learn more about what you can do.

Our-position

12 years ago, several leading German companies including Boehringer Ingelheim came together to launch Afrika Kommt! Learn more about it here.

We create Value through Innovation for our customers

We create value through innovation for our customers. Discover how we live our Leitbild. Click here to find out more and to access related articles.

Our Purpose

Find out what 'transforming lives' and 'for generations' means for our work and long-term thinking here. Click here to learn more about our purpose.

Marek's Disease Poultry Chicken

Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems. Learn more here.

Our Expectations

We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. Click here to learn more.

Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug

Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.

We are powered by our people

We nurture a diverse, collaborative and open environment, which appeals to the best people. Click here to discover how else we live our Leitbild.

About Us

Human Health

Animal Health